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Abstract The present study was undertaken to characterise the
phosphodiesterases (PDEs) present in brown adipose tissue
(BAT) of Zucker rat pups and to determine whether the capacity
for degradation of cyclic nucleotides was affected by the fatty
genotype. Regardless of the genotype, PDE2^4 contributed to
total PDE activity, the PDE3 activity equalling the sum of
PDE2 and 4 activities. In fa/fa compared to Fa/fa rats, (a) PDE2
activity was significantly increased, (b) Western blot analysis of
PDE2 revealed two signals at 71 and 105 kDa, with changes in
protein being in good parallelism with changes in activity, (c) the
PDE2 mRNA concentration was also significantly increased. In
good agreement, the cGMP concentration was decreased in BAT
from fa/fa pups.
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1. Introduction
In the Zucker obese (fa/fa) rat, obesity is genetically trans-
mitted as an autosomal recessive trait due to a mutation on a
single gene that has been called ‘fa’, for fatty. A single nucleo-
tide substitution in the fa allele of the leptin receptor is re-
sponsible for the obese phenotype [1]. Because leptin acts on
the brain to inhibit feeding and to increase thermogenesis [2],
this mutation produces profound obesity of early onset caused
by defective non-shivering thermogenesis [3,4] and preferential
deposition of energy into white adipose tissue [5].
Brown adipose tissue (BAT) is the main e¡ector of non-
shivering thermogenesis in a new-born rat and therefore plays
an important role in the positive energy balance at the onset
of obesity. In Zucker fa/fa rats, before obesity is clearly ap-
parent, numerous metabolic abnormalities are present in the
BAT [4,6,7] and can be corrected by administration of ther-
mogenic L-adrenergic agonists [8,9], suggesting that impaired
sympathetic activity is one of the ¢rst consequences of the
gene’s expression. Furthermore, cellular responsiveness to cat-
echolamines is altered in BAT [10], thus demonstrating that
the capacity for 3P,5P-cyclic monophosphate (cAMP) produc-
tion is decreased in fa/fa neonates.
The intracellular concentration of cAMP results from an
equilibrium between production and degradation. The 3P,5P-
cyclic nucleotide phosphodiesterases (PDEs) are responsible
for the degradation of the second messenger cyclic nucleotides
cAMP and cGMP. They are important in regulating intra-
cellular concentrations of cyclic nucleotides and, conse-
quently, biological responses to these molecules. Mammalian
PDEs include a large group of structurally related isoenzymes,
which belong to at least seven distinct but related gene fam-
ilies [11]. Because they are di¡erently expressed and regulated,
PDEs are found in di¡erent amounts, proportions and sub-
cellular locations in di¡erent cells and tissues. In white adipo-
cytes, cGMP-inhibited cAMP phosphodiesterase plays a key
role in the anti-lipolytic action of insulin [12] and accounts for
80% of the phosphodiesterase activity in the non-soluble frac-
tion of these cells [13]. However, cGMP-stimulated PDE
(PDE2) and cAMP-speci¢c PDE (PDE4) have also been char-
acterised in a soluble fraction from extract of rat epididymal
fat cells [13].
In BAT, PDE3 is present and the hormonal regulation of
this PDE form is thought to be similar to that in white adi-
pose cells [14]. However, neither the presence of the other
PDE forms nor their relative contributions to phosphodiester-
ase activity has been investigated in this tissue. The present
study was undertaken to characterise the PDEs present in
BAT of Zucker rats and to determine whether the capacity
for cAMP degradation by these di¡erent phosphodiesterase
isoforms was a¡ected by the fatty genotype. Because the en-
docrine status of obese rats is strongly modi¢ed after weaning,
we examined PDE(s) activities in young pre-obese (fa/fa) and
lean (Fa/fa) Zucker rats at 14 days of age.
2. Materials and methods
2.1. Animals and protocols
Zucker rats were bred in our laboratory from obese (fa/fa) male and
heterozygous lean (Fa/fa) female crosses. The pups and their mother
were housed in a temperature-controlled room (22 þ 1‡C) on a ¢xed
12:12 h light/dark cycle (lights on from 07:00 h to 19:00 h). The dams
were fed on a stock diet (UAR, France) ad libitum. The litter size was
standardised at 10 pups which were used at 14 days of age. The
genotype of the pups was identi¢ed through study of the correlation
between inguinal adipose weight and body weight [15].
2.2. Tissue sampling and processing
Rats of either sex were killed by decapitation and interscapular
BAT was carefully dissected and immediately frozen in liquid nitrogen
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for further homogenisation or for isolation of RNA. Three tissues
(300^400 mg) were homogenised with a glass-Te£on homogeniser in
3 ml of ice-cold 10 mM TES/250 mM sucrose bu¡er (pH 7.0) con-
taining 0.5 Wg/ml each of leupeptin, pepstatin, aprotinin and 100 Wm
4-(2-aminoethyl)benzensulfonyl £uoride hydrochloride. The extract
was defatted by centrifugation at low speed (1000Ug for 10 min at
4‡C). Soluble and particulate fractions were prepared from the result-
ing infranatant by high speed centrifugation (100 000Ug for 40 min at
4‡C). The resulting pellet was resuspended in 200 Wl of homogenisa-
tion bu¡er. In defatted homogenates and in both the soluble and the
particulate fractions, the proteins were measured according to the
method of Bradford [16] and PDE activity was determined.
2.3. Preparation of BAT cells
10 Tissues were minced and digested at 37‡C with the combination
of collagenase and DNAse I as described by Omatsu-Kanbe et al. [14].
The £oating fractions containing brown adipose cells were washed
three times in Krebs Ringer bicarbonate HEPES bu¡er (120 mM
NaCl, 4 mM KH2PO4, 1 mM MgSO4, 1 mM CaCl2, 10 mM
NaHCO3, 30 mM HEPES, pH 7.4) containing 2.5 mM glucose and
200 nM adenosine and then homogenised and processed as described
above. Cells were kept at 37‡C until homogenisation.
2.4. cAMP-PDE assay
cAMP-PDE activity was assayed according to Degerman et al. [17].
Radiolabelled [3H]cAMP substrate was puri¢ed by thin layer chroma-
tography on cellulose plates and by anion-exchange chromatography
on DEAE-Sephadex. Samples were incubated at 30‡C for 10 min, in a
total volume of 0.3 ml containing 50 mM HEPES (pH 7.4), 0.1 mM
EGTA, 8.3 mM MgCl2 and 0.1 WM [3H]cAMP (20 000 dpm). The
reaction was stopped by addition of 0.1 ml HCl (1 N) containing
12 WM cAMP and 6 WM 5P-AMP. After neutralisation by 0.1 ml
Tris (0.25 M, pH 8.0) and incubation of the reaction mixture at
30‡C for 20 min with 2 Wg snake venom nucleotidase (Crotalux atrox,
Sigma, St. Louis, MO, USA) in 0.1 ml Tris (0.1 M, pH 8.0),
[3H]adenosine was separated from intact [3H]cAMP by chromatogra-
phy on DEAE-Sephadex and collected into vials for liquid scintilla-
tion counting. Hydrolysis of substrate did not exceed 20%. Under
these conditions, cAMP-PDE activity was called ‘basal activity’ and
was proportional to the enzyme concentration. All assays were done
in duplicate. PDE activities are expressed as units (U), where 1 U
catalyses the hydrolysis of 1 Wmol of cyclic nucleotide in 1 min at
30‡C.
Substrate-speci¢cities and inhibitors were used for distinguishing
PDE activities [11]. Inhibitors were routinely dissolved as stock sol-
utions in dimethyl sulfoxide (DMSO) and subsequently diluted with a
maximum concentration of 0.3% being employed in the assay. Such
concentrations of DMSO did not a¡ect the various PDE activities.
PDE4 activity was estimated by the di¡erence between the activity
measured in basal conditions and the activity measured in the pres-
ence of 5 WM 4-(3-cyclopentyloxyphenyl)-2-pyrrolidone (a highly spe-
ci¢c PDE4 inhibitor).
PDE3 activity was estimated as the fraction of basal PDE activity
inhibited by 0.5 WM N-cyclohexyl-N-methyl-4-(1,2-dihydro-2-oxo-6-
quinolyloxy) butiramide (cilostamide).
PDE2 activity could be gauged by measuring the increase in cAMP
hydrolysis caused by a low cGMP concentration. Addition of low
concentrations of cGMP might also be expected to inhibit PDE3
activity leading to a reduction of cAMP. However, using both the
highly selective PDE3 inhibitor, cilostamide [17], and a low concen-
tration of cGMP (1 WM), PDE2 activity could be assessed by the
di¡erence between activity measured in the above conditions and
the basal activity.
2.5. Western blot analysis
5 Wg protein of the soluble fraction was electrophoresed on a 10%
SDS-polyacrylamide gel, electroblotted and incubated with a 1/1000
dilution of a biotinylated anti-PDE2 protein antibody from rabbit.
The immune complex was incubated with streptavidin-horseradish
peroxidase conjugate (RPN.1231, Amersham, France) and detected
by an ECL Western blotting system (Amersham, France).
2.6. Northern blot analysis
Total RNA from frozen tissues was extracted by guanidinium thi-
ocyanate according to Chirgwin et al. [18]. RNA was analysed by
Northern blotting after electrophoresis on a 1% agarose and 0.66 M
formaldehyde gel and was transferred by capillarity to nylon mem-
branes (Nybon N, Amersham). Hybridisation was performed with a
[32P]cDNA probe encoding bovine brain PDE2 [19].
To verify the amount of total RNA in each lane, the blots were also
hybridised with a synthetic oligonucleotide (ACGGTATCT-
GATCGTCTTCGAACC), speci¢c for ribosomal 18S RNA. Quanti-
¢cation was performed by scanning densitometry. Assuming that 18S
RNA did not vary with the genotype, values were normalised for the
corresponding amount of 18S RNA.
2.7. cGMP assay
cGMP was extracted from tissue homogenates using columns con-
taining anion-exchange silica sorbents (Amprep SAX, Amersam) and
the level of cyclic nucleotide was determined by a radioimmunoassay
(Amersham TRK 500).
2.8. Statistical analysis
Results are expressed as mean þ S.E.M. The level of signi¢cance in
the di¡erence between groups was calculated by Student’s t-test.
3. Results
Activities of total cAMP-PDE in homogenates, cytosolic
and particular fractions of BAT are presented in Table 1.
Within each fraction, the total PDE activity was not a¡ected
by the genotype. Independently of the genotype, 40^45% of
the PDE activity was recovered in the cytosolic fraction.
PDE3 activity (Table 2) was found to account for half of
the total PDE activity in BAT homogenates and was mainly
located in the particulate fraction. Taken together, these data
show that a large part of the PDE activity was recovered in
the cytosolic fraction and could not be attributable to PDE3.
Fig. 1 shows activities of PDE3 in the particular fraction
and those of PDE2 and PDE4 in the cytosolic fraction of (A)
isolated brown adipose cells and (B) tissue homogenates. In
fa/fa compared to Fa/fa rats, the speci¢c activity of PDE2 in
brown fat cells was increased by 50% (Fig. 1A).
When measurements were performed in fractions from
tissue homogenates (Fig. 1B), PDE(s) activities displayed a
similar pattern except for PDE4 which was slightly but sig-
ni¢cantly increased in fa/fa compared to Fa/fa rats. However,
it could not be excluded that a part of the PDE4 activity in
BAT homogenates was due to contamination by monocytes,
lymphocytes and leukocytes in which several subtypes of
Table 1
PDE activity in BAT of 14 days old Zucker rats
PDE activity (U per whole tissue)
Genotype n Homogenate Particular fraction Soluble fraction
Fa/fa 4 871 þ 47 227 þ 11 402 þ 40
fa/fa 4 827 þ 39 208 þ 9 339 þ 23
Homogenate, particulate and soluble fraction were prepared as de-
scribed in Section 2. Data are means þ S.E.M., n is the number of
animals.
Table 2
Activity of PDE3 in BAT of 14 days old Zucker rats
PDE3 activity (percentage of total activity per whole tissue)
Genotype n Homogenate Particular fraction Soluble fraction
Fa/fa 4 47 þ 1.1 73 þ 1.8 31 þ 2.8
fa/fa 4 43 þ 1.4 68 þ 1.8 31 þ 1.9
Homogenate, particular and soluble fraction were prepared as de-
scribed in Section 2. PDE3 activity was estimated as the fraction of
basal activity that could be inhibited by cilostamide. Data are
means þ S.E.M., n is the number of animals.
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PDE4 are highly expressed [20]. Thus, the very small di¡er-
ence between fa/fa and Fa/fa pups could result from blood
contamination.
Immunoblotting of PDE2 in BAT is presented in Fig. 2. In
BAT from Zucker rats, the antiserum detected a signal at 105
kDa close to puri¢ed PDE2 from bovine cardiac tissue, bo-
vine adrenal tissue and rabbit brain [11] but also one signal at
71 kDa which corresponds probably to a proteolytic product
of the larger form as it has been observed in rat liver [21].
Both the 105 and the 71 kDa signals were multiplied by two in
fa/fa compared to Fa/fa rats. These variations of PDE2 con-
centrations in BAT paralleled those observed for enzyme ac-
tivities (Fig. 1).
Northern blot analysis of PDE2 (Fig. 3) revealed that the
concentration of mRNA was signi¢cantly increased in BAT of
fa/fa compared to Fa/fa pups (Fig. 3).
cGMP concentrations were measured in BAT of Zucker
rats. There was a signi¢cant 25% decrease in the level of
cGMP in BAT of pre-obese compared to lean rats
(22.1 þ 1.06 versus 29.3 þ 1.42, P6 0.01 for 12 fa/fa versus
13 Fa/fa).
4. Discussion
4.1. Isoforms of PDE in BAT
The expression of PDE(s) has been poorly investigated in
BAT. However, the presence of PDE3 mRNA in this tissue
was ¢rst demonstrated by in situ hybridisation [22] and the
regulation of this isoform is thought to be similar to that in
white adipose cells [14]. The data provided in this study con-
¢rm that PDE3 is present in BAT but they also show that
activity of this isoform represents only half of the total PDE
activity, thus suggesting that other PDE(s) play a role in the
degradation of cAMP. As it has been shown in white adipose
tissue [17], PDE3 in BAT is mainly located in the particulate
fraction of homogenate. Our results also show that at least
three forms of PDE were active in brown adipocytes of rat.
The fact that the slight increase in PDE4 activity found in
tissue of fa/fa rats could not be evidenced in isolated brown
fat cells suggests that a little part of PDE4 activity in tissue
Fig. 1. Activities of PDE(s) in (A) isolated brown adipose cells and
in (B) BAT of 14 days old fa/fa and Fa/fa Zucker rats. Activities
were estimated in the absence (basal PDE activity) or in the pres-
ence of selective inhibitors or activators (for details, see Section 2).
Data are means þ S.E.M. of four experiments, they are expressed as
percentages of the level detected in basal conditions (A) per mg pro-
tein for isolated cells and (B) per whole tissue. *, P6 0.05, Fa/fa
versus fa/fa rats.
Fig. 2. Quantitative analysis of the PDE2 protein isoform in BAT
of 14 days old Zucker rats. A representative Western blot is shown
in the upper panel. The intensity of the bands was measured by
scanning densitometry. Data are means þ S.E.M., they are expressed
as percentages of the level detected in lean Fa/fa rats. *, P6 0.05,
10 Fa/fa versus 10 fa/fa rats.
Fig. 3. PDE2 mRNA levels in BAT of 14 days old Zucker Fa/fa
and fa/fa rats. Data are means þ S.E.M. of analysis from 13 Fa/fa
and 15 fa/fa. PDE2 mRNA levels were normalised to the 18S RNA
content and are expressed as percentages of the level detected in
lean Fa/fa rats. **, P6 0.01, fa/fa versus Fa/fa.
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homogenates resulted from contamination by other cell types.
However, due to the great di¡erence in both the size and lipid
content of brown adipose cells between obese and lean rats,
£oating adipocytes after collagenase treatment of the tissue
did not re£ect whole tissue cellularity. Thus, the expression
of PDE4 could not be accurately investigated in BAT of
Zucker pups and we focused our attention on that of PDE2
whose activity measured either in isolated cells or in tissue was
signi¢cantly increased in fa/fa compared to Fa/fa rats.
4.2. E¡ect of the fa gene on PDE2 expression
The present study reveals for the ¢rst time that PDE2 is
overexpressed in BAT of pre-obese fa/fa rats. The increase in
PDE2 mRNA content of BAT is proportional to the increase
in both the PDE2 protein concentration and the PDE2 activ-
ity. Therefore, in the mutant fatty rat, the control of PDE2
gene expression is exerted at a pre-translational level.
Of the major classes of PDEs, the PDE2 is unique in ex-
hibiting positively co-operative kinetics for hydrolysis of both
cAMP and cGMP [11]. We have previously shown that the
capacity for cAMP production was signi¢cantly decreased in
BAT of fa/fa pups as compared with their lean Fa/fa litter-
mates [10]. This study provides evidences that in fa/fa rats, a
signi¢cant increase in the expression of PDE2 was well-corre-
lated with a decrease of the cGMP concentration, but the
biological function of PDE2 in BAT is nevertheless not de-
¢ned. Most of the actions of cGMP are believed to be medi-
ated by protein kinase G whose expression in brown fat has
never been investigated. In brown adipocytes di¡erentiated in
culture, addition of a cGMP analogue suppresses lipoprotein
lipase activity [23] and it could be expected that a fall in the
concentration of cGMP would increase the enzyme activity.
However, lipoprotein lipase expression is signi¢cantly reduced
in BAT of fa/fa compared to Fa/fa pups [8], thus strongly
suggesting that variations of the cGMP concentration in the
physiological range did not a¡ect lipoprotein lipase activity in
BAT.
It has been shown that PDE2 could account for a substan-
tial portion of total cAMP hydrolysis in several bovine tissues
[24]. In BAT of fa/fa pups, the overexpression of PDE2 could
also play a role in regulation of the intracellular cAMP con-
centration and therefore could contribute to the defective ac-
tivation of thermogenesis in this tissue [4].
In summary, this study shows that in BAT from rats, ac-
tivities of both the PDE2 and PDE4 are comparable to that of
PDE3. In pre-obese Zucker pups, PDE2 expression is in-
creased and consequently, the cGMP concentration is de-
creased. These data together with previous results [10] clearly
demonstrate that production of cyclic nucleotides is strongly
altered in BAT of 14 days old Zucker fa/fa rats. However, the
connection between mutation in the gene encoding the leptin
receptor and the regulation of PDE2 expression is not clear
and further investigations are needed to study the factors in-
volved in this process.
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